Cargando…
Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors
BACKGROUND: ICIs have remarkably affected the treatment strategies for numerous malignancies, including lung cancer. However, only a fraction of patients experience durable responses to ICIs; thus, there is an urgent need to identify the parameters related to ICI therapeutic effects. In this study,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336031/ https://www.ncbi.nlm.nih.gov/pubmed/35902908 http://dx.doi.org/10.1186/s12885-022-09744-5 |